MEDP: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net income	315,990	204,855
Depreciation	20,284	13,471
Amortization	709	473
Stock-based compensation expense	29,166	22,843
Noncash lease expense	17,329	11,687
Deferred income tax provision (benefit)	63,366	34,856
Other	433	520
Accounts receivable and unbilled, net	77,119	81,980
Prepaid expenses and other current assets	15,607	33,130
Accounts payable	1,296	12,021
Accrued expenses	57,521	12,249
Advanced billings	123,743	98,198
Lease liabilities	-18,131	-12,615
Other assets and liabilities, net	-2,457	8,046
Net cash provided by operating activities	520,571	274,362
Property and equipment expenditures	26,820	16,107
Other	-153	-100
Net cash used in investing activities	-26,667	-16,007
Proceeds from stock option exercises	34,272	26,285
Repurchases of common stock	917,389	912,815
Net cash (used in) provided by financing activities	-883,117	-886,530
Effect of exchange rates on cash, cash equivalents, and restricted cash	5,128	5,069
(decrease) increase in cash, cash equivalents, and restricted cash	-384,085	-623,106
Cash and cash equivalents at beginning of period	669,436	-
Cash and cash equivalents at end of period	285,351	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

MEDP: the cashflow